cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Indaptus Therapeutics Inc
9 own
8 watching
Current Price
$2.44
$0.08
(3.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
17.64M
52-Week High
52-Week High
4.08000
52-Week Low
52-Week Low
1.56000
Average Volume
Average Volume
0M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization17.64M
icon52-Week High4.08000
icon52-Week Low1.56000
iconAverage Volume0M
iconDividend Yield--
iconP/E Ratio--
What does the Indaptus Therapeutics Inc do?
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.
Read More
How much money does Indaptus Therapeutics Inc make?
News & Events about Indaptus Therapeutics Inc.
Globe Newswire
11 months ago
Dr. Newman also to give two presentations on the Companys Decoy platform at the event to be held in Boston May 9-11, 2023NEW YORK, May 01, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, Indaptus or the Company), a biotechnology company focused on discovering and developing ...
Globe Newswire
1 year ago
Data presented were crucial to initiating its ongoing Phase 1 clinical trial with Decoy 20 in solid tumorsNEW YORK, April 19, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, Indaptus or the Company), a biotechnology company focused on discovering and developing transformative ...
Globe Newswire
1 year ago
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announcesthat it will participate at the Investor Summit Conference being held virtually on March 29...
Globe Newswire
1 year ago
Enrollment Underway in Phase 1 Clinical Trial of Decoy20 for Treatment of Solid Tumors with First Patient Dosed In March 2023NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (Indaptus or the Company), today announced financial results for the fourth quarter and...
Globe Newswire
1 year ago
NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, Indaptus or the Company), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announces that the American Association for Cancer Research (AACR) has ...
Frequently Asked Questions
Frequently Asked Questions
What is Indaptus Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Indaptus Therapeutics Inc shares?
plus_minus_icon
How can I buy Indaptus Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Indaptus Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Indaptus Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Indaptus Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Indaptus Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Indaptus Therapeutics Inc?
plus_minus_icon
What percentage is Indaptus Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Indaptus Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.44
$0.08
(3.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00